Use the search parameters below to filter talks:

Calendar
Calendar

2013 - IPITA 2013 Congress (Monterey)

Mini-Oral Session 5 on Clinical Pancreas Transplantation 2
26 September 2013  /  11:00 - 12:30

Autoantibody monitoring in the follow-up of pancreas transplant recipients

Presenter: Fanny Buron, Lyon, France

- Autoantibody monitoring in the follow-up of pancreas transplant recipients

Presenter: Fanny Buron, Lyon, France

Evaluation of pancreatic graft survival using 11C-Methionine Positron Emission Tomography after living donor and cadaveric donor pancreas transplantation

Presenter: Kazunori Otsuki, Chiba, Japan

- Evaluation of pancreatic graft survival using 11C-Methionine Positron Emission Tomography after living donor and cadaveric donor pancreas transplantation

Presenter: Kazunori Otsuki, Chiba, Japan

Elevated BMI does not affect outcome in Type II diabetics undergoing whole organ pancreas transplantation

Presenter: William Bry, San Francisco, United States

- Elevated BMI does not affect outcome in Type II diabetics undergoing whole organ pancreas transplantation

Presenter: William Bry, San Francisco, United States

Outcomes of a new category of pancreas transplantation; pancreas after islet transplantation (PAI)

Presenter: Garrett Roll, San Francisco, United States

- Outcomes of a new category of pancreas transplantation; pancreas after islet transplantation (PAI)

Presenter: Garrett Roll, San Francisco, United States

The Metabolic Effects of Tacrolimus and Sirolimus on Insulin Secretion and Insulin Resistance in Pancreas-Kidney Transplant Recipients

Presenter: Richard Knight, Houston, United States

- The Metabolic Effects of Tacrolimus and Sirolimus on Insulin Secretion and Insulin Resistance in Pancreas-Kidney Transplant Recipients

Presenter: Richard Knight, Houston, United States

Pancreas Transplantation in African American Compared to Non African American Recipients: Does Recipient Ethnicity Influence Outcomes?

Presenter: Robert J. Stratta, Winston-Salem, United States

- Pancreas Transplantation in African American Compared to Non African American Recipients: Does Recipient Ethnicity Influence Outcomes?

Presenter: Robert J. Stratta, Winston-Salem, United States

Single Center Analysis of Mortality in 202 Consecutive Pancreas Transplants

Presenter: Robert J. Stratta, Winston-Salem, United States

- Single Center Analysis of Mortality in 202 Consecutive Pancreas Transplants

Presenter: Robert J. Stratta, Winston-Salem, United States

5 Year Results of a Prospective Randomized Single Center Study of Alemtuzumab Compared to Rabbit Anti-Thymocyte Globulin Induction in Kidney-Pancreas Transplantation

Presenter: Robert J. Stratta, Winston-Salem, United States

- 5 Year Results of a Prospective Randomized Single Center Study of Alemtuzumab Compared to Rabbit Anti-Thymocyte Globulin Induction in Kidney-Pancreas Transplantation

Presenter: Robert J. Stratta, Winston-Salem, United States

Sonographic findings following pancreas transplantation

Presenter: Tara Morgan, San Francisco, United States

- Sonographic findings following pancreas transplantation

Presenter: Tara Morgan, San Francisco, United States

Pro vs Con Debate
27 September 2013  /  11:00 - 12:30

Current Development of Innovative Insulin Therapy: toward closed-loop glucose control at home

Presenter: Eric Renard, Montpellier, France

- Current Development of Innovative Insulin Therapy: toward closed-loop glucose control at home

Presenter: Eric Renard, Montpellier, France

Beta Cell Replacement Therapy

Presenter: Bernhard J. Hering, Minneapolis, United States

- Beta Cell Replacement Therapy

Presenter: Bernhard J. Hering, Minneapolis, United States

Parallel Session 1 on Clinical Allogeneic Islet Transplantation
25 September 2013  /  11:00 - 12:30

Islet allotransplantation in type 1 diabetes: phase 2 pilot study with CXCL8 inhibitor (reparixin).

Presenter: Paola Maffi, Roma, Italy

- Islet allotransplantation in type 1 diabetes: phase 2 pilot study with CXCL8 inhibitor (reparixin).

Presenter: Paola Maffi, Roma, Italy

Hepatic steatosis after intraportal Islet After Kidney (IAK), Islet Tranplantation Alone (ITA) and Islet Auto Tranplantation (IAT) in 108 patients: prognostic value of ultrasound on clinical outcome

Presenter: Paola Maffi, Roma, Italy

- Hepatic steatosis after intraportal Islet After Kidney (IAK), Islet Tranplantation Alone (ITA) and Islet Auto Tranplantation (IAT) in 108 patients: prognostic value of ultrasound on clinical outcome

Presenter: Paola Maffi, Roma, Italy

Long-term outcomes of clinical islet transplantation using donors after cardiac death: A multicenter experience in Japan

Presenter: Takayuki Anazawa, Fukushima, Japan

- Long-term outcomes of clinical islet transplantation using donors after cardiac death: A multicenter experience in Japan

Presenter: Takayuki Anazawa, Fukushima, Japan

Restoration of glucose counterregulation by islet transplantation in long standing type 1 diabetes

Presenter: Michael Rickels, Philadelphia, United States

- Restoration of glucose counterregulation by islet transplantation in long standing type 1 diabetes

Presenter: Michael Rickels, Philadelphia, United States

COST ANALYSIS OF WHOLE PANCREAS TRANSPLANT VERSUS ISLET TRANSPLANT IN ADULTS WITH TYPE ONE DIABETES (T1D).

Presenter: Sara Moassesfar, San Francisco, United States

- COST ANALYSIS OF WHOLE PANCREAS TRANSPLANT VERSUS ISLET TRANSPLANT IN ADULTS WITH TYPE ONE DIABETES (T1D).

Presenter: Sara Moassesfar, San Francisco, United States

Mini-Oral Session 6 on Clinical Islet Transplantation - Engraftment and graft monitoring
26 September 2013  /  11:00 - 12:30

Clinical impact of allogenic islet transplantation in 55 patients under ATG induction therapy and Tacrolimus-MMF maintenance immunosuppression

Presenter: DaHae Lee, Leuven, Belgium

- Clinical impact of allogenic islet transplantation in 55 patients under ATG induction therapy and Tacrolimus-MMF maintenance immunosuppression

Presenter: DaHae Lee, Leuven, Belgium

Reversible, moderate and early alteration of kidney function in non-uremic type 1 diabetic islet recipients under tacrolimus-mycophenolate maintenance therapy

Presenter: Pieter Gillard, Leuven, Belgium

- Reversible, moderate and early alteration of kidney function in non-uremic type 1 diabetic islet recipients under tacrolimus-mycophenolate maintenance therapy

Presenter: Pieter Gillard, Leuven, Belgium

Central Retinal Artery (CRA) flow velocity: Color Doppler Ultrasound (CDUS) assessment in type 1 diabetic patients after Kidney-Pancreas (KP), Kidney-Alone (KA) and Islet Transplantation Alone (ITA)

Presenter: Paola Maffi, Roma, Italy

- Central Retinal Artery (CRA) flow velocity: Color Doppler Ultrasound (CDUS) assessment in type 1 diabetic patients after Kidney-Pancreas (KP), Kidney-Alone (KA) and Islet Transplantation Alone (ITA)

Presenter: Paola Maffi, Roma, Italy

Reassembly of alpha and beta cells of neo-islet tissues engineered in the subcutaneous space by islet-cell sheet transplantation in mice

Presenter: Hirofumi Shimizu, Fukushima, Japan

- Reassembly of alpha and beta cells of neo-islet tissues engineered in the subcutaneous space by islet-cell sheet transplantation in mice

Presenter: Hirofumi Shimizu, Fukushima, Japan

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi